Programme

En anglais seulement

INSCRIVEZ-VOUS


Day 1: Wednesday, February 10, 2021

6:00 PM - 7:00 PM (EST)

KEYNOTE ADDRESS: 
At the Heart of Women’s Health: Sex, Gender and Intersectionality

By the end of the session, participants will be able to describe how the COVID-19 pandemic has left its impact on every aspect of our lives – including women’s hearts. By unmasking and exacerbating existing sex, gender, and racial disparities in health and disease, the pandemic has paved a clear path for effective rehabilitation and recovery. Sex, gender, and intersectionality are key determinants for early detection, accurate diagnosis and equitable treatment for diverse women living with or at risk of heart disease. Strategies to mitigate bias in research methods and clinical care are critical for rectifying inequities. Participants will be better positioned to chart a new roadmap for women’s heart health in Canada and internationally.

Dr. Cara Tannenbaum

Cara Tannenbaum, MD, MSc
Canadian Institutes of Health Research | Montréal, QC
 
 
 

Day 2: Thursday, February 11, 2021


10:00 AM - 11:00 AM (EST)

THEME 1: Cardiovascular Disease & Co-Morbidities
Heart Disease and Co-Morbidities – A Long and Winding Road

By the end of the session, participants will be able to explore issues surrounding multiple conditions/ co-morbidities as so many diseases are intertwined and share common risk factors.

Paula Harvey, BMBS, PhD, FRACP
Women’s College Hospital | Toronto, ON

 

11:00 AM - 12:00 PM (EST)

THEME 2: Heart, Brain & Mind Connection
The Heart-Mind Connection from a Patient’s Perspective

By the end of the session, participants will be able to describe a woman's journey from a healthy young woman to a stroke survivor and cardiomyopathy patient who is concerned about her own cognitive future. 

Jennifer Monaghan, LLB, BA
Woman with Lived Experience | Kelowna, BC

 
Stroke in Women

By the end of the session, participants will be able to recognize the frequency, risk factors, and outcomes after stroke in women.

Dr. Moira Kapral

Moira K. Kapral, MD, MSc, FRCPC
University Health Network and Toronto General Hospital
Toronto, ON

Vascular Cognitive Impairment in Women

By the end of the session, participants will be able to identify differences in the epidemiology, clinical manifestations, treatment, and outcomes of vascular cognitive impairment in women.

Jodi Edwards, PhD
University of Ottawa Heart Institute | Ottawa, ON

 
Mental Health as a Determinant of Cardiovascular Health in Women

By the end of the session, participants will be able to describe the role of mental health and its implications on cardiovascular risk in women.

Heather Tulloch, PhD
University of Ottawa Heart Institute | Ottawa, ON


 

1:00 PM - 2:00 PM (EST)

THEME 3: The Valves
Women with Cardiac Disease (Congenital and Acquired) Learning to Become Their Own Health Advocates - My Story

By the end of the session, participants will be able to describe Lori's personal journey through the healthcare system and the importance of advocating for your own health and know that you are not alone.

Lori Constable-SmolcicLori Constable-Smolcic, RN, BScN
Woman with Lived Experience | Mississauga, ON

 

Sex Differences in Prevalence, Clinical Manifestations and Medical Management of Valvular Heart Disease

By the end of the session, participants will be able to identify the sex differences in prevalence, clinical manifestations and medical management of valvular heart disease in women.

Maurice Enriquez-Sarano, MD, FACC, FAHA, FESC
Mayo Clinic | Rochester, MN

 
Sex Considerations in Percutaneous Management of Valve Disease

By the end of the session, participants will be able to  explain the sex differences in the prevalence and diagnosis of valvular heart disease and sex considerations in the treatment of valvular heart disease.

Dr. Anita AsgarAnita Asgar, MD, FRCPC, FACC
Montréal Heart Institute | Montréal, QC

 

Sex Considerations in Surgical Management of Valve Disease

By the end of the session, participants will be able to  examine sex considerations in surgical management of valve disease in women. 

Maral Ouzounian, MD, PhD
University Health Network | Toronto, ON


 

2:00 PM - 3:00 PM (EST)

THEME 4: The Coronary Arteries: A Novel Perspective
My Heart Story

By the end of the session, participants will be able to describe Sudi's personal journey from symptom recognition, diagnosis, treatment, and her road to recovery.

Sudi BarreSudi Barre
Woman with Lived Experience | Edmonton, AB

 
What's New in Spontaneous Coronary Artery Dissection (SCAD)? 

By the end of the session, participants will be able to describe recent developments in the optimal diagnosis and management of SCAD.

Sharonne Hayes, MD, FACC, FAHA
Mayo Clinic | Rochester, MN

 
Are There Still Disparities in PCI Outcomes in Women in Contemporary Practice? The Patient vs the Doctor

By the end of the session, participants will be able to describe whether there are disparities in PCI outcomes in women and consider whether any differences in outcomes are because of the adverse risk factor profile of women or whether they are due to sub-optimal treatment. 

Mamas A. Mamas, BM, BCh, MA, DPhil, MRCP
Keele University | Stoke on Trent, UK

 
Unique Aspects of Surgical Revascularization in Women

By the end of the session, participants will be able to describe the factors that contribute to surgical strategy for coronary revascularization in men and women as well as the potential effects of these decisions on patient outcomes in both sexes.

Dr. Janet NguJanet Ngu, MSc, FRCSC
Cleveland Clinic  | Cleveland, OH, USA

 


3:00 PM - 4:00 PM (EST) 

Concurrent Sessions:
1. Hot Topics in Cardio-Obstetrics

By the end of the session, participants will be able to focus on conditions during pregnancy that provide risk for heart diseases later in life.

University of Calgary | Calgary, AB
 

 
2. The Intersection of Breast Cancer and Heart Disease

By the end of the session, participants will be able to describe how shared risk factors influence prevention and treatment of both diseases.

Dr. Michele TurekMichele Turek, MDCM, FRCPC
University of Ottawa Heart Institute and The Ottawa Hospital | Ottawa, ON

 

Dr. Husam Abdel-QadirHusam Abdel-Qadir, MD, PhD, FRCPC
Women’s College Hospital and University Health Network | Toronto, ON

 

3. Aspirin for Primary Prevention in Women: Should I use it in 2021?

By the end of the session, participants will be able to describe the latest evidence on aspirin with clinical strategies for appropriate patient selection.

Dr. Erin MichosErin Michos, MD, MHS, FACC, FAHA, FASE
Johns Hopkins University School of Medicine | Baltimore, MD

 

4. Become a Community Leader and Advocate for Women's Cardiovascular Health

By the end of the session, participants will be able to describe the various programs and initiatives from across Canada aimed at educating and supporting women with cardiovascular disease.

Dr. Jillianne Code

Jillianne Code, PhD
Woman with Lived Experience | Vancouver, BC

 
Marion Martell

Marion Martell
Woman with Lived Experience | Ottawa, ON


Jackie Ratz, BA hons
Woman with Lived Experience | Winnipeg, MB



4:00 PM - 5:00 PM (EST)

THEME 5: Before and After the Diagnosis - Unique Challenges in Prevention & Rehabilitation
Charlotte's Experience with Symptoms, Time to care, Treatment and Recovery

By the end of the session, participants will be able to explain the challenges and benefits of cardiac rehabilitation programs.

Charlotte Girard
Woman with Lived Experience | Otterburn Park, QC

 

Primary Prevention: Unique Aspects for Women

By the end of the session, participants will be able to describe sex-specific nuances in the implementation of the 2019 U.S. Guidelines for the Primary Prevention of Cardiovascular Disease (CVD). These include 1)  the consideration of  female-specific risk enhancing factors and coronary artery calcium (if measured) to guide decisions for statin therapy, 2) the role of aspirin, and 3) patient-centered approach to CVD prevention. 

Erin Michos, MD, MHS, FACC, FAHA, FASE
Johns Hopkins University School of Medicine | Baltimore, MD

 

Sex-Specific Barriers to Cardiac Rehabilitation: How to Overcome Them?

By the end of the session, participants will be able to describe female-specific barriers to participation in cardiac rehabilitation and identify strategies to overcome barriers and optimize participation.

Dr. Tracey ColellaTracey J.F. Colella, PhD, RN
University Health Network | Toronto, ON

 

Discovering the Impact of Peer Support on Psycho-Social Well-Being: the Women @ Heart Experience

By the end of the session, participants will be able to describe how social support for women is an essential component of cardiac rehabilitation.

Robert Reid, PhD, MBA
University of Ottawa Heart Institute | Ottawa, ON




6:00 PM - 7:00 PM (EST) 

Achieving Gender Equity in Medicine and Leadership: A Strategy for Improving Women’s Cardiovascular Health

By the end of the session, participants will be able to describe individual, systemic and structural opportunities and barriers to advancing women in healthcare leadership.

Sharonne Hayes, MD, FACC, FAHA
Mayo Clinic | Rochester, MN



7:00 PM - 8:00 PM (EST)

Twitter Journal Club: Top 2 Studies that Advance Women's Heart Health in the Last Two Years

By the end of the session, participants will be able to interpret the latest research results in the field of women’s heart health from the top two studies that advanced women’s heart health in the last two years. To view this content, visit the @CWHHS Twitter Page and search #CWHHSJournalClub.

Dr. Karin Humphries

Karin H. Humphries, MBA, DSc, FAHA
University of British Columbia | UBC-Heart & Stroke Foundation BC Centre for Improved Cardiovascular Health | Vancouver, BC

 

Dr. Jordan Hutson

Jordan H. Hutson, MD, FRCPC
Critical Care Fellow
Department of Medicine, University of Ottawa  | Ottawa, ON

 


DAY 3: Friday, February 12, 2021


10:00 AM - 11:00 AM (EST) 

THEME 6 - The Vessels: the Aorta, Pulmonary & Peripheral Arteries
My Path in the Medical System

By the end of the session, participants will be able to describe Judith's personal experience with being diagnosed, course of treatment, and managing life with the disease.

Judith MoattiJudith Moatti
Woman with Lived Experience, Canadian PAH Ambassador | Montréal, QC

 

Sex Differences in Aortic Aneurysms and Dissections

By the end of the session, participants will be able to identify differences in the epidemiology, clinical manifestations, treatment and outcomes of aortic aneurysms and dissections in women.

Thais Coutinho, MD
University of Ottawa Heart Institute | Ottawa, ON

 

Peripheral Arterial Disease in Women

By the end of the session, participants will be able to describe the differences in presentation and clinical outcomes for women with peripheral arterial disease.

Dr. Amy PollakAmy West Pollak, MD, MS-CR
Mayo Clinic | Jacksonville, FL

 

Sex Differences in Pulmonary Hypertension

By the end of the session, participants will be able to identify differences in the epidemiology, clinical manifestations, treatment and outcomes of pulmonary hypertension in women.

Lisa Mielniczuk, MD, FRCPC
University of Ottawa Heart Institute | Ottawa, ON

 

11:00 AM - 12:00 PM (EST) 

Rapid-Fire Oral Presentations

By the end of the session, participants will be able to interpret new experiences, insights, and latest research results in the field of women’s heart health from our summit delegates.



1:00 PM - 2:00 PM (EST) 

Emerging Needs as a Woman in the COVID-19 Era
Equity: the Heart of Women’s Health

By the end of the session, participants will be able to describe the big picture impact on women in society during these unprecedented times.

Genesa GreeningGenesa M. Greening
President + CEO, BC Women's Health Foundation | Vancouver, BC

 

The Importance of considering Sex and Gender in COVID-19 Research

Present and discuss the importance of incorporating a sex and gender analysis to improve the effectiveness of health interventions and promote gender and health equity goals.

Dr. Colleen NorrisColleen Norris, PhD, MSc, BScN, RN, FAHA 
University of Alberta | Edmonton, AB

 

COVID-19: A Tale of Two Pandemics

By the end of the session, participants will be able to better understand the disparities endured during the current climate with potential recommendations and solutions.

Dr. Gianni LorelloGianni R. Lorello, BSc, MD, MSc (Med Ed), CIP, FRCPC
Toronto Western Hospital, University Health Network, University of Toronto, The Wilson Centre and Womens' College Hospital | Toronto, ON

 


3:00 PM - 4:00 PM (EST) 

Concurrent Sessions
1. Communicating with Your Healthcare Provider: How to Maximize Your Time and Optimize Your Health

By the end of the session, participants will be able to review tips and techniques for patients to communicate with their healthcare provider.

Nadia LappaNadia Lappa
Woman with Lived Experience | Ottawa, ON

 

Dr. Krystina B. LewisKrystina B. Lewis, RN, MN, PhD, CCN(C)
University of Ottawa | Ottawa, ON

 

2. Addressing the Gaps: One Project at a Time (Canadian Women’s Heart Health Alliance)

By the end of the session, participants will be able to describe the launch and current activities of a national alliance of experts in, and advocates for, women's cardiovascular health. Participants will summarize how this Alliance helps develop and disseminate evidence-informed strategies to transform clinical practice and enhance collaborative action on women's cardiovascular health in Canada.

Dr. Beth AbramsonBeth L. Abramson, MD, MSC, FRCPC, FACC
St. Michael's Hospital and University of Toronto | Toronto, ON

 

Dr. Thais CoutinhoThais Coutinho, MD
University of Ottawa Heart Institute | Ottawa, ON

 

Karen E. Jacques

Karen E. Jacques, JD
Woman with Lived Experience | Kincardine, ON

 

Dr. Sharon MulvaghSharon L. Mulvagh, MD, FRCP(C), FACC, FAHA, FASE
Mayo Clinic, Dalhousie University and QEII Health Sciences Centre | Halifax, NS

 

Dr. Colleen NorrisColleen Norris, PhD, MSc, BScN, RN, FAHA 
University of Alberta | Edmonton, AB

 

Dr. Tara Sedlak

Tara L. Sedlak, MD, FRCPC
Vancouver General, St. Paul’s, and UBC Hospitals | Vancouver, BC

 

3. Circadian Medicine and Women's Heart Health

By the end of the session, participants will be able to describe the critical role of circadian biology for cardiovascular health, and how translational application of the new field of Circadian Medicine will improve treatment of patients with cardiovascular disease in both biological sexes.

Dr. Tami MartinoTami A. Martino, PhD
University of Guelph | Guelph, ON

 

4. Sex-Specific Considerations in Obesity and Lipid Metabolism

By the end of the session, participants will be able to describe how gonadal hormones and sex chromosomes each influence fat storage and lipid levels and contribute to sex-specific risk for diseases such as obesity and atherosclerosis.

Dr. Karen Reue

Karen Reue, PhD
University of California at Los Angeles (UCLA) | Los Angeles, CA




4:00 PM - 5:00 PM (EST) 

THEME 7: Heart Failure
Patient Perspective

By the end of the session, participants will be able to describe a woman’s personal journey through the healthcare system from symptom recognition, heart disease diagnosis, treatment, and outcomes.

Jackie RatzJackie Ratz, BA Hons
Woman with Lived Experience | Winnipeg, MB

 

Sex-Specific Differences in Heart Failure Care and Outcomes: Closing the Gap

By the end of the session, participants will be able to describe the sex-based differences in characteristics, care, and outcomes among patients with heart failure. To make recommendations that close the sex-based gaps in care among patients with heart failure.

Harriette G.C. Van Spall, MD, MPH, FRCPC
McMaster University | Hamilton, ON

 

What is new in Heart Failure with Preserved Ejection Fraction (HFpEF)?

By the end of the session, participants will be able to describe the latest on pathophysiology and clinical issues of HFpEF and potential reasons for female predominance.

Shelley Zieroth, MD
St. Boniface Hospital | St. Boniface, MB

 

Advanced Heart Failure Therapies: Do Women Benefit as Much as Men?

By the end of the session, participants will be able to discuss the latest in heart failure therapies and whether women benefit as much as men.

Mary Norine Walsh, MD, MACC
St. Vincent Heart Centre | Indianapolis, IN


 

7:00 PM - 8:00 PM (EST) 

THE DEBATE: Can Social Media Positively Transform Knowledge Translation for Women’s Heart Health?

By the end of the session, participants will be able to identify the role of social media in medicine, and specifically for women’s heart health, for research, education, advocacy and sharing knowledge on a world-wide level. This session will share the best practices for the use of social media for health care professionals.

Caroline LavalléeCaroline Lavallée (Moderator)
Woman with Lived Experience | Montréal, QC

Martha Gulati, MD, MS, FACC, FAHA, FASPC (For)
College of Medicine - Phoenix and the University of Arizona | Phoenix, AZ

 

Paul Oh, MSc, MD, FRCPC (Against)
Toronto Rehabilitation Institute | Toronto, ON

 


Day 4: Saturday, February 13, 2021


11:00 AM - 12:00 PM (EST) 

KEYNOTE ADDRESS: 
Putting the Pieces of the Puzzle Together:  Advancing the Journey to Equity for Women's Heart Health

By the end of the session, participants will be able to recognize the following as important components to improve healthcare for women at risk for heart disease: 1)The healthcare delivery systems needs that are necessary to increase awareness of CVD in women; 2)The expanded approach to curriculum to educate healthcare professionals; 3)The need for an expanded sex and gender CVD research agenda.

Jennifer H. Mieres, MD, FACC, MASNC, FAHA
Northwell Health | New York, NY

 

12:00 - 12:15pm

Awards Ceremony and Closing Remarks

Thais Coutinho, MD
University of Ottawa Heart Institute | Ottawa, ON

Dr. Michele TurekMichele Turek, MDCM, FRCPC
University of Ottawa Heart Institute and The Ottawa Hospital | Ottawa, ON

 


 

Other Links
French